维普中文期刊产品整合服务
76篇 您的检索式:作者名="Hanis T"
    题名 作者 年代 出处 被引量
1Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism显示文摘BACKGROUND Gastrointestinal cancer(GICA)is associated with a higher incidence of venous thromboembolism(VTE)compared to other solid tumors,moreover,recurrent VTE and major bleeding(MB)complications during anticoagulation treatment have an associated increase rate.GICA-VTE remains a challenging clinical scenario with MB concerns for utilization of direct oral anticoagulants(DOAC),especially with active cancer therapies.AIM To evaluate patient risk factors,effectiveness(VTE)and safety(MB)of DOACs and low molecular weight heparin(LMWH)in patients with active GICA-VTE.METHODS A retrospective chart review of patients receiving DOACs and LMWH with GICA and symptomatic or incidental VTE treated at comprehensive cancer center from November 2013 to February 2017 was performed.Inclusion criteria included active GI cancer diagnosed at any stage or treatment+/-6 mo of VTE diagnosis,whom were prescribed 6 mo or more of DOACs or LMWH.The Chi-squared test was used for overall and the Fisher exact test for pairwise comparisons of the proportions of patients experiencing recurrent VTE and MB events.Odds ratios were used to compare the relative odds of the occurrence of the outcome given exposure to the risk factor.RESULTS A total of 144 patients were prescribed anticoagulation,in which 106 fulfilled inclusion criteria apixaban(27.3%),rivaroxaban(34.9%)and enoxaparin(37.7%),and 38 were excluded.Patients median age was 66.5 years at GICA diagnosis and 67 years at CAVTE event,with 62%males,80%Caucasian,70%stage IV,pancreatic cancer(40.5%),30%Khorana Score(≥3 points),and 43.5%on active chemotherapy.Sixty-four percent of patients completed anticoagulation therapy(range 1 to 43 mo).Recurrent VTE at 6 mo was noted in 7.5%(n=3),6.8%(n=2)and 2.7%(n=1)of patients on enoxaparin,apixaban and rivaroxaban,respectively(all P=NS).MB at 6 mo were 5%(n=2)for enoxaparin,6.8%(n=2)for apixaban and 21.6%(n=8)for rivaroxaban(overall P=0.048;vs LMWH P=0.0423;all other P=NS).Significant predictors of a primary or secondary outcome for all anticoagulation therapies included:Active systemic treatment(OR=5.1,95%CI:1.3-19.3),high Khorana Score[≥3 points](OR=5.5,95%CI:1.7-17.1),active smoker(OR=6.7,95%CI:2.1-21.0),pancreatic cancer(OR=6.8,95%CI:1.9-23.2),and stage IV disease(OR=9.9,95%CI:1.2-79.1).CONCLUSION Rivaroxaban compared to apixaban and enoxaparin had a significantly higher risk of MB on GICA-VTE patients with equivocal efficacy.Alejandro Recio-Boiles Sumana Veeravelli Jessica Vondrak Hani M Babiker Aaron J Scott Rachna T Shroff Hitendra Patel Emad Elquza Ali McBride 2019World Journal of Gastrointestinal Oncology2019,11,10:3
2Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours:a comparison with PET/CT显示文摘Fischer MA Nanz D Hany T 0,,02:1
3How useful is PET/CT imaging in the management of post-transplant lym-phoproliferative disease after liver transplantation? 显示文摘McCormack L Hany T I Hiibner M 2006Am J Transplant2006,6,7:1
4MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death pro- tein 4 (PDCD4) 显示文摘hani S Kunisada T Morimoto Y 2012J Cancer Res Clin Oncol2012,,9:1
5Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography显示文摘Ruehm SG Hany TF Pfammater T 2000Am J Roentgenol2000,174,:1
6Diagnostic accuracy of whole-bodyMRI/DWI image fusion for detection of malignant tumours: A comparison with PET/CT显示文摘Fischer MA Nanz D Hany T 2011European Journal of Radiology2011,21,2:1
7Current-mode triple and quadruple langmuir probe methods with applications to flowing pulsed plasmas 显示文摘Gatsonis N A Byrne L T Zwahlen J C Pencil E J and Kamhawi Hani 2004IEEE Transactions on Plasma Science2004,32,5:1
8Integrated PET/CT for the assessment of coronary artery disease:A feasibility study显示文摘Namdar M Hany T F Koepfli P 2005J Nucl Med2005,46,:1
9Staging of non-small cell lung cancer with integrated positron emission tomography and computed tomography显示文摘LARDINOIS D WEDER W HANY T F 2003N Engl J Med2003,348,25:1
10On the Interaction of UV-B radiation(280-315 nm)with water stress in crop plants显示文摘Balakumar T Hani B V V Paliwal K 1993Physiol Plant1993,87,:1
11Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vesscls显示文摘Wieben O Grist T M Hany T F 2002Radiology2002,225,5:1
12A Case Study on Evaluations of Improvements Implemented by WISE Projects in the Philippines显示文摘Takeyama H hany T Taehi N 2006Ind Health2006,44,:1
13PET diagnostic accuracy improvement with in line PET-CT system: initial results显示文摘HANY T F STEINERT H C GOERRES G W 2002Radiology2002,225,2:1
14Fertility of mice receiving vit-rified adult mouse ovaries显示文摘Hani T Tachibe T Shingai S 2006Reproduction2006,131,4:1
15Detection of HIV-1 viruses in tears of patients even under long-term HAART 显示文摘HanY WuN ZhuW LiY ZuoL YeJ QiuZ XieJ Li T 2011AIDS2011,25,15:1
16Pelvic and lower extremity arterial imaging:diagnostic performance of three-dimensional contrast-enhanced MR angiography显示文摘Ruehm SG Hany TF Pfammatter T 2000AJR2000,174,4:1
17Variation of 2-acetyl-l-pyrroline con- centration in aromatic rice grains collected in the same region in Japan and factors affecting its concentration显示文摘hani T Tamaki M Hayata Y 2004Plant Prod Sci2004,7,2:1
18Toward Non-Toxic Anti- fouling: Synthesis of Hydroxy -, Cinnamic Acid -, Sulfate -, and Zosteric Acid- Labeled Poly 显示文摘Hany R Bohlen C Geiger T 2004Biomacromolecules2004,5,4:1
19Model for coordination of com- munity health services and health and welfare services offered by health insurance societies显示文摘Terada H hani T Shoji S 2003Sangyo Eiseigaku Zasshi2003,45,2:1
20Effect of pressure at primary drying of freeze-drying mouse sperm reproduction ability and preservation potential 显示文摘Kawase Y Hani T Kamada N 2007Reproduction2007,133,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费